MedPath

Study on combined effect of oral intake of vasakadi kvatha and katakadi anjana eye drops in diabetic retinopathy

Not Applicable
Conditions
Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications
Registration Number
CTRI/2022/02/039922
Lead Sponsor
Dr S Vidyasagar badisa
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient aged between 20 to 70 yrs.

2. Type 1 or Type 2 diabetes mellitus

3. Patients with visual symptoms blurring of vision and floaters.

4. Fundoscopic findings revealing at least one micro aneurysm or intra retinal hemorrhage at least in two to three quadrants.

5. Presence of hard exudates.

6. Early mild IRMA

7. Patients reading and willing to sign the informed consent form.

Exclusion Criteria

1. Known case of Gestational Diabetes mellitus. 2. Patients with complete loss of vision or sudden unexplained severe loss of vision.

3. Patients associated with other diagnosed systemic disorders renal, cerebrovascular disease.

4. Patients with known case of glaucoma and central cataract.

5. Patients with signs of retinal detachment, acute vitreous hemorrhage.

6. Other types of Retinopathies like-Hypertensive Retinopathy1, Retinopathies of blood dyscrasias.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate changes in best corrected visual acuityTimepoint: Baseline data 15th day 30th day 45th day 60th day
Secondary Outcome Measures
NameTimeMethod
To evaluate the amount of micro aneurysms.Timepoint: Baseline data 15th day 30th day 45th day 60th day
© Copyright 2025. All Rights Reserved by MedPath